Oragenics (NYSE:OGEN) Now Covered by StockNews.com
The Cerbat Gem -

StockNews.com began coverage on shares of Oragenics (NYSE:OGEN – Free Report) in a research report report published on Friday morning. The firm issued a sell rating on the stock. Oragenics Stock Performance Shares of NYSE:OGEN opened at $1.50 on Friday. Oragenics has a 1 year low of $1.00 and a 1 year high of $7.74. […]

Related Articles

Latest in News

More from The Cerbat Gem | Oragenics NYSE:OGEN OGEN Medical Initiated Coverage StockNews.com Analyst Articles Finance